← Books, chapters & reports

FROM THE PURSER BOOKSHELF · CHAPTER GUIDE

Reduced glutathione: formulations and patent claims

Learn how formulation, storage, and delivery differ from proof of a health benefit.

Based on teaching by Dan Purser, MD. How we prepare these guides

Educational summary

Why this matters

Learn how formulation, storage, and delivery differ from proof of a health benefit.

How the pieces connect

Products can differ in stability, storage, and delivery. Ask which formulation and route were studied and what benefit was measured.

Three product questions that should stay separate

Stability asks whether a preparation maintains its intended composition. Bioavailability asks how much reaches a relevant site after administration. Clinical efficacy asks whether using it improves a meaningful outcome. A preparation can answer one question well while leaving another unanswered. Dr. Purser discusses all three around reduced glutathione, but they should not be collapsed into a single claim of “functionality.” The formulation, route and study population must match the claim being considered.

Keep in mind

A patent or delivery claim tells you about a product idea, not whether it treats disease. Ask for evidence about the specific formulation and the health outcome you care about.

A question for your next conversation

Which of the three questions does the evidence actually answer?

BUILD YOUR UNDERSTANDING

A few concepts, made clearer.

Glutathione (GSH)

A molecule made from glutamate, cysteine and glycine that participates in cellular redox balance.

Read the full reference

LET YOUR CURIOSITY LEAD

One idea opens another.

Choose a subject to find the related teaching across videos, articles, courses and references.